Insider trades
Andrew C. Orth, Chief Officer of Krystal Biotech KRYS, has filed 0 purchases and 3 sales on the open market. The latest trade was on 23/06/09.
Andrew C. Orth
Chief Commercial Officer
- Company
- Krystal Biotech KRYS
- First filing
- 23/02/28
- Trades
- 7 trades
- Buys / sales
- 0 / 3
- 12-month net buying
- No record
- Last trade
- 23/06/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
KRYS | Open-market sale10b5-1 plan | 23/06/09 | 23/06/09 | 12,500 sh3 trades | $128.61avg. | $1,607,583.84 | −99.2% |